Interviews

Compound Management Today: Abbvie's Head of Compound Management Tells All | 13th Compound and Sample Management Summit

Compound Management Today: Abbvie's Head of Compound Management Tells All | 13th Compound and Sample Management Summit

Carsten Aprill, Head of Compound Management, Abbvie GmbH and Co KG, speaks to Pharma IQ about how automation has redefined compound management and which technology he thinks has had the best compound management application. Aprill also shares his top tip for a successful compound management strategy.

Pfizer & Merck on Trends in Compound & Sample Management | 13th Compound and Sample Management Summit

Pfizer & Merck on Trends in Compound & Sample Management | 13th Compound and Sample Management Summit

What are the biggest logistical challenges for global sample management? How have automated workflows improved the drug delivery process? What quality control methods are most effective? Cindy Schulz, Manager, Logistics & Data Management, Pfizer and Catherine Quintero, Senior Research Scientist, Merck Boston answer these questions and more about the trends in Compound and Sample Management. 

Top Tips for Managing Compounding Issues With Agility | 13th Compound and Sample Management Summit

Top Tips for Managing Compounding Issues With Agility | 13th Compound and Sample Management Summit

Researchers and engineers handling time and temperature-sensitive substances work together despite cultural boundaries and differing technological workflows, which is a process that requires expertise and agility. How does one achieve this? To answer this question we asked two past speakers to share their expertise on workflows, automation and outsourcing.

SPEAKER SPOTLIGHT: William Janzen, Executive Director, Lead Discovery, Epizyme | 13th Compound and Sample Management Summit

SPEAKER SPOTLIGHT: William Janzen, Executive Director, Lead Discovery, Epizyme | 13th Compound and Sample Management Summit

In lead up to the 13th Compound and Sample Management Summit, we sat down with William Janzen, Executive Director, Lead Discovery at Epizyme for industry insight into the challenges that both small and big pharma face, as well as key trends to look out for.